Lexicon Pharma Voluntarily Withdraws Sotagliflozin New Drug Application
28/2 13:28
(RTTNews) - Lexicon Pharmaceuticals, Inc. (LXRX) announced the voluntary withdrawal and planned near-term resubmission of the company's New Drug Application for sotagliflozin to correct a technical issue with the submission recently identified by the company....